Connect with us


Emerald Health Therapeutics Inc. (OTCMKTS: EMHTF) Reports 23% YoY Revenue Increase in Q2 2021



Emerald Health Therapeutics Inc. (OTCMKTS: EMHTF)  has announced its Q2 2021 and 1H 2021 financial results and offered business highlights. 

Net sales in Q2 were $3.04 million 

Net sales during the quarter were up 23% YoY to $3.04 million and increased 35% QoQ.  However average selling price per gram dropped to $3.28 in Q2 2021 from $3.65 in the first quarter. Emerald reported a net loss of $13.97 million, including a non-cash impairment of $10.97 million of assets held for sale. The company reported a negative EBITDA of $2.69 million in Q2 and improved from Q1’s EBITDA loss of $2.84 million.

CEO Riaz Bandali said, “In the second quarter we started to see incremental progress in executing on our renewed business strategy, resulting in a 42% sequential quarterly increase in gross revenue to $3.8M, with a concurrent significant improvement to just a small negative gross margin. Our net operating loss and cash flow utilization have improved and we ended the quarter with over $32M in working capital, providing us with significant runway.  We also made key additions to our team with the appointment of Moe Jiwan as Chief Operating Officer and, recently, Nick Mosgrove as VP Sales & Marketing, both experienced leaders.”

Emerald launched SYNC tablets 

In April, the company launched a new sublingual tablet, SYNC Tabs, under its wellness brand. The tablet is a naturally-flavored ingestible that offers a controlled 10mg THC dose. SYNC will be available to customers at licensed retailers and online across Canada. 

Bandali added, “With our commitment to science-based innovation and our Defined Dose focus to offer health, wellness and medical consumers more precise and predictable dosing and a more consistent cannabis consumption experience, our R&D efforts resulted in the launch of our new SYNCTM Tabs and, in July, FUSE Nano Shots. Our SYNC medical product sales are robust and our Quebec Souvenir brand, which now includes a Souvenir-branded strain-specific oil, has started to establish additional sales momentum in Quebec.”

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.


Business2 days ago

CytoDyn Inc (OTCMKTS: CYDY) Announces Study to Investigate Leronlimab for Triple-negative Breast Cancer Treatment

Post Views: 18 CytoDyn Inc (OTCMKTS: CYDY) has announced that there will be a study on the drug leronlimab and...

Business2 days ago

Curaleaf Holdings Inc (OTCMKTS: CURLF) Completes Acquisition of Los Sueños Farms

Post Views: 38 Curaleaf Holdings Inc (OTCMKTS: CURLF) has completed the acquisition of the most enormous outdoor grow in Colorado,...

Business2 days ago

BAE SYSTEMS ADR (OTCMKTS: BAESY) and Keep Scotland Beautiful Launch Cleaning Hub in Govan

Post Views: 14 BAE SYSTEMS ADR (OTCMKTS: BAESY), a designer, developer and manufacturer of aerospace systems used in space, land,...

Business2 days ago

Charlotte’s Web Holdings Inc (OTCMKTS: CWBHF) Announces it Will Expand Distribution Following Passing of Assembly Bill 45

Post Views: 10 Charlotte’s Web Holdings Inc (OTCMKTS: CWBHF) has announced that it will expand product distribution in California following...

Technology3 days ago

BAE Systems Inc. (OTCMKTS: BAESY) Granted five-year $68.5 Million Air Traffic Control Contract

Post Views: 12 BAE Systems Inc. (OTCMKTS: BAESY) has been picked for a 5-year $68.5M indefinite-quantity, indefinite-delivery contract enabling it...

Business3 days ago

CytoDyn Inc (OTCMKTS: CYDY) Announces Appointments of New Chief Operating Officer and Senior Executive Vice President

Post Views: 30 CytoDyn Inc (OTCMKTS: CYDY) has announced that it has appointed Nitya Ray, Ph.D., to act as its...